These "gray-market" drugs bypass FDA manufacturing and purity standards
Clinical trials consistently demonstrate GLP-1 agonists produce significant weight loss and improve cardiovascular outcomes in people with obesity or type 2 diabetes
Personalized Care: Each treatment plan is customized to your wellness goals
By selecting the right brand, you can ensure that you are getting a high-quality product that can effectively support your health and well-being
J Cell Biol 208(6):70311 Castro Dias M, Odriozola Quesada A, Soldati S, Bsch F, Gruber I, Hildbrand T et al (2021) Brain endothelial tricellular junctions as novel sites for T cell diapedesis across the bloodbrain barrier
It is not yet well-understood how these bacteria can exert these benefits, but documented mechanisms of action include antimicrobial activity against major gastrointestinal 171 and urogenital pathogens 172 , barrier-promoting effects at the gut epithelium 173 and other mucosa 174 , immunomodulatory effects by stimulating host antimicrobial compounds such as - defensins 175 and modulating the secretion of cytokines such as IL-10, IL-6, IL-1b, IL-2, TNF-, and impacting different cell types such as intestinal epithelial cells, dendritic cells, macrophages and regulatory T cells 176,177,178